Hyperliquid Strategies (NASDAQ:PURR) Given New $6.00 Price Target at Cantor Fitzgerald

Hyperliquid Strategies (NASDAQ:PURR) had its target price upped by equities researchers at Cantor Fitzgerald from $5.00 to $6.00 in a research note issued on Thursday,Benzinga reports. The firm currently has an “overweight” rating on the stock. Cantor Fitzgerald’s price objective would indicate a potential upside of 32.16% from the company’s previous close.

Separately, Chardan Capital increased their price objective on shares of Hyperliquid Strategies from $8.15 to $8.45 and gave the company a “buy” rating in a research report on Thursday. Two investment analysts have rated the stock with a Buy rating, According to data from MarketBeat, the stock presently has a consensus rating of “Buy” and a consensus price target of $7.23.

Hyperliquid Strategies Price Performance

Shares of PURR stock remained flat at $4.54 during midday trading on Thursday. The company’s stock had a trading volume of 742,110 shares, compared to its average volume of 3,094,259. Hyperliquid Strategies has a 1 year low of $3.01 and a 1 year high of $5.78. The stock has a market cap of $576.72 million, a P/E ratio of -1.34 and a beta of 1.57.

Hyperliquid Strategies (NASDAQ:PURR) last issued its earnings results on Wednesday, February 11th. The company reported ($7.43) earnings per share (EPS) for the quarter.

Hyperliquid Strategies Company Profile

Hyperliquid Strategies Inc is a digital asset treasury company whose primary focus is to maximize shareholder value through accumulating HYPE, the native token of Hyperliquid, a high-performance blockchain custom-built to house all of finance. Hyperliquid Strategies Inc, formerly known as Sonnet BioTherapeutics Holdings Inc, is based in NEW YORK.